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Previewspolar body transfer is complicated by the
need to identify pronuclear gender, which
is relatively easy in mice though more
complicated in primates.
The ultimate objective of this body of
work is to initiate human clinical trials, in
carrier women with a prior affected child,
in efforts to prevent disease transmission
in subsequent children. Since mitochon-
drial replacement involves germline gene
therapy, however, such approaches are
currently restricted. Regulatory agencies
in the United States and United Kingdom
are evaluating safety and efficacy issues
based on animal model studies such as
Wang et al., 2014 and those described
herein (Callaway, 2014); however, it re-8 Cell Metabolism 20, July 1, 2014 ª2014 Elsmains to be seen when authorization will
be forthcoming and whether polar body
transfer will be included as an approved
approach.
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One of the biggest challenges in biology is to understand how mitochondria influence aging and age-related
diseases. Chin et al. (2014) reveal how a mitochondrial metabolite (mitobolite) inhibits mitochondrial ATPase
and extends lifespan by mimicking dietary restriction in worms.The free radical theory of aging proposes
that accumulating macromolecular dam-
age due to increased reactive oxygen
species over time causes aging. As
mitochondria are believed to be the
main contributors of free radicals,
reducing mitochondrial electron transport
chain function would be expected to in-
crease lifespan. Several studies in nema-
todes, flies, and mice have corroborated
this idea by demonstrating that genetic
inhibition of several mitochondrial com-
ponents, especially those of the electron
transport chain (ETC) complexes, can
extend lifespan (Aguilaniu et al., 2005).
However, several findings in the field
have diminished the enthusiasm for the
idea that simply the inhibition of mito-
chondrial function or even free radicals
will extend lifespan in mammals. Further-
more, restricting nutrients in mammals or
flies is accompanied by enhancement
of mitochondrial biogenesis and function(Guarente, 2008; Zid et al., 2009). This
in principle opposes the ‘‘Warburg ef-
fect,’’ as the enhancement of mitochon-
drial function helps the organism switch
from glycolysis to oxidative metabolism,
which mediates the protective effects of
dietary restriction, such as slowing aging
and decreased cancer rates. How and
when an organism reduces mitochon-
drial function to extend lifespan, how-
ever, remains unclear. Recent work by
Jing Huang and colleagues suggests
that a mitochondrial metabolite (mito-
bolite) extends lifespan by inhibition of
mitochondrial ATPase through mecha-
nisms overlapping with dietary restriction
in Caenorhabditis elegans (Chin et al.,
2014).
Mitochondrial tricarboxylic acid cycle
(TCA) metabolites, such as pyruvate,
fumarate, malate, and oxaloacetate,
have been previously shown to extend
lifespan upon feeding in C. elegans (Mou-chiroud et al., 2011; Williams et al., 2009),
though the mechanistic underpinnings
of the prolongevity effects remain to be
delineated. Chin et al. now add a-ketoglu-
tarate (KG) to the list of ‘‘youthful’’ TCA
intermediates. Using a novel, unbiased
technique, DARTS (drug affinity respon-
sive target stability), they identify the bind-
ing proteins of KG that may explain its
effects on aging. In this assay, cell lysates
were incubated in varying concentrations
of KG, followed by a complete proteoly-
sis by a mixture of proteases, with the
assumption that if KG is binding to a
protein, that protein or the associated
fragment will be protected from protease
action. Uncleaved fragments were sepa-
rated on a gel and further identified
by liquid chromatography-tandem mass
spectrometry. Chin et al. found that KG
binds to several proteins, including two
subunits of mitochondrial ATPase. Using
several biochemical assays, including
Figure 1. The Role of Mitochondria-Derived Metabolites, ‘‘Mitobolites,’’ in Modulating
Metabolism, Growth, and Longevity
Interventions that modulate mitochondrial functions regulate the flux of mitobolites. Mitobolites (red dots)
potentially regulate mitochondrial proteins, including mitochondrial ATPase (black structures), and once
released from mitochondria, these mitobolites may also regulate cellular signaling pathways. This in
turn modulates various physiological processes like metabolism, growth, and longevity.
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Previewsmeasurement of ATPase activity, respira-
tion in isolated mitochondria, and mea-
surement of ATP levels in worms after
KG feeding, the authors confirmed that
KG indeed inhibits mitochondrial ATPase
activity. Consistently, reduction of atp2
(C. elegans mitochondrial ATPase b sub-
unit) by RNAi led to increased lifespan,
which was not further increased by KG
feeding.
One consequence of inhibition of mito-
chondrial ATPase is reduction in cellular
ATP levels. This in turn could lead to
increased AMP and activation of the
energy-sensing kinases such as AMP ki-
nase. The authors observed a reduction
in ATP levels, though the lifespan exten-
sion upon KG feeding was not dependent
on AMPK or hypoxia-inducible factor-1a.
Inhibition of target of rapamycin (TOR),
which mediates the effects of dietary
restriction in multiple species (Kapahi
et al., 2010), did not further extend life-
span upon KG feeding. However, the
longevity effects were dependent on
pha-4, known to be critical for life-
span extension by dietary restriction in
C. elegans (Panowski et al., 2007). The au-
thors also demonstrated that KG inhibits
TOR in both human and mouse cell lines,
though themechanisms of this interaction
remain to be elucidated. Consistent
with the effects of inhibition of TOR, auto-
phagy was enhanced in worms fed with
KG, treated with oligomycin (ATPase
inhibitor), or carrying atp-2 mutations.
Together, these results suggest that KG-
dependent ATPase inhibition modulatesautophagy in a TOR-dependent manner
to extend lifespan.
When defining the impact ofmodulating
mitochondrial function, there tends to be
an overemphasis on measuring ROS and
ATP levels, which fails to take into consid-
eration the dynamic role of ‘‘mitobolites’’
(Figure 1). Mitochondria originated by
endosymbiosis, and over time they lost
most of their DNA, which normally plays
an important role in responding to envi-
ronmental perturbations. However, mito-
bolites may act as the key sensors of
mitochondrial perturbations and mediate
nuclear-mitochondrial interactions. The
study by Chin et al. adds to the emerging
evidence on the growing role of such
mitobolites in modulating metabolism,
growth, disease processes, and longevity
(Chandel, 2014). Many unanswered ques-
tions remain about mitobolites. How is the
mitochondrial metabolite flux regulated?
How are levels of various metabolites in-
tegrated to code for certain responses?
What are the different targets, and their
tissue specificity, that are regulated by
the secreted mitobolites? Also, what is
the role of non-TCA mitobolites in aging
such as those generated by fatty acid
oxidation, urea cycle, cardiolipin syn-
thesis, heme, quinone, and steroid
biosynthesis? Recent studies have indi-
cated that the exometabolome (metabo-
lite excreted in the environment by the
worm) of long-lived mitochondrial mu-
tants is significantly different from short-
lived mitochondrial mutants or other
animals (such as insulin receptor mutant,Cell Metabodaf-2), supporting the possibility that
mitobolites can further extend lifespan in
certain long-lived mutants (Butler et al.,
2010, 2013). Thus, one may have to inte-
grate the levels of various mitobolites
and the cellular state to decipher how
each perturbation will influence the down-
stream events to modulate aging.
The elucidation of the mechanism by
which KG inhibits mitochondrial ATPase
and mimics the effects of dietary re-
striction underscores the important role
mitobolites play as potential signaling
molecules. Wider appreciation of the role
of mitobolites will not only help resolve
some of the paradoxes in the field but
also provide excellent therapeutic targets
to counteract aging and age-related dis-
eases in mammals.ACKNOWLEDGMENTS
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